Placebo
Dietary SupplementSugar pill containing maltodextrin.
Other names: Placebo, non-active components
NCT Number: NCT01190358
The purpose of this study is to determine whether taking grape seed extract prior to eating a high fat meal will reduce the inflammatory response in people with the metabolic syndrome.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
University of California Davis (Academic Surge, Ragle Human Nutrition Research Facility), Davis, California, United States
The purpose of this study is to determine whether taking grape seed extract prior to eating a high fat meal will reduce the inflammatory response in people with the metabolic syndrome. If this extract is shown to mitigate the inflammatory response induced by a high fat meal, it could potentially aid in postponing of the diagnosis of diabetes or other chronic diseases associated with high levels of inflammation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The metabolic syndrome will be diagnosed on the basis of having a combination of any 3 of the following factors:
Exclusion criteria
Sugar pill containing maltodextrin.
Other names: Placebo, non-active components
Meganatural Gold® contains 300mg of grape seed extract.
Other names: Active, Meganatural Gold®
Time frame: 7 hours
Analysis of inflammatory markers known to increase following a meal high in fat (~40% kcal from fat). Markers to be analyzed will include the following:
Time frame: 7 hours
Assay for the insulin and glucose response generated from consumming a high fat meal (~40% of kcal from fat).
University of California, Davis
Other
Grape Seed Extract and Postprandial Oxidation and Inflammation: A Pilot Study in People With the Metabolic Syndrome.
Acronym: GSEMetS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05956886
Dyssomnias, Glucose Metabolism Disorders
Newark, Delaware, United States
View Trial DetailsNCT07739602
Glucose Metabolism Disorders, Hyperinsulinism
Wroclaw, Poland
View Trial DetailsNCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT07702669
Glucose Metabolism Disorders, Hyperinsulinism
Harbin, Heilongjiang, China
View Trial Details